Literature DB >> 16926828

Pharmacotherapeutics of migraine and the blood-brain barrier: serendipity, empiricism, hope, and hype.

Vinod K Gupta.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16926828      PMCID: PMC1785228     

Source DB:  PubMed          Journal:  MedGenMed        ISSN: 1531-0132


× No keyword cloud information.
  8 in total

Review 1.  Migraine--current understanding and treatment.

Authors:  Peter J Goadsby; Richard B Lipton; Michel D Ferrari
Journal:  N Engl J Med       Date:  2002-01-24       Impact factor: 91.245

2.  Magnesium therapy for migraine: do we need more trials or more reflection?

Authors:  Vinod Kumar Gupta
Journal:  Headache       Date:  2004-05       Impact factor: 5.887

3.  Migraine, cortical excitability and evoked potentials: a clinico-pharmacological perspective.

Authors:  Vinod Kumar Gupta
Journal:  Brain       Date:  2005-09       Impact factor: 13.501

4.  Botulinum toxin type A therapy for chronic tension-type headache: fact versus fiction.

Authors:  V K Gupta
Journal:  Pain       Date:  2005-07       Impact factor: 6.961

5.  Topiramate for migraine prophylaxis: addressing the blood-brain barrier-related pharmacokinetic-pathophysiological disconnect.

Authors:  V K Gupta
Journal:  Int J Clin Pract       Date:  2006-03       Impact factor: 2.503

6.  Prophylaxis of migraine and mixed headache. A randomized controlled study.

Authors:  N T Mathew
Journal:  Headache       Date:  1981-05       Impact factor: 5.887

Review 7.  Emerging drugs for migraine prophylaxis and treatment.

Authors:  Marcelo E Bigal; Abouch V Krymchantowski
Journal:  MedGenMed       Date:  2006-05-04

8.  Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin.

Authors:  H H Krämer; C Angerer; F Erbguth; M Schmelz; F Birklein
Journal:  J Neurol       Date:  2003-02       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.